Caplin Point Laboratories (NSE:CAPLIPOINT, BOM:524742) consolidated attributable profit rose to 1.70 billion Indian rupees in the fiscal fourth quarter ended March 31, from 1.43 billion rupees a year ago.
Earnings per share came in at 22.31 rupees from 18.69 rupees a year earlier, the pharmaceutical company said in a filing to the Indian stock exchanges on Thursday.
Revenue from operations in fiscal Q4 also increased to 6.00 billion rupees from 5.02 billion rupees a year ago.
The company's board declared an interim dividend of 4 rupees per equity share of face value of 2 rupees each for the financial year ended March 31.
Caplin Point's shares were up over 10% in recent trade.